Clincosm LogoSign in Get a demo

relapsed and refractory multiple myeloma

Showing 1 - 10 of 10
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed and Refractory Multiple Myeloma Trial in Pittsburgh (Mezigdomide, Ixazomib, Dexamethasone)

Not yet recruiting
  • Relapsed and Refractory Multiple Myeloma
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Sep 15, 2023

Multiple Myeloma, Relapsed and Refractory Multiple Myeloma Trial in Chengdu (HG146)

Recruiting
  • Multiple Myeloma
  • Relapsed and Refractory Multiple Myeloma
  • Chengdu, Sichuan, China
    HitGen Inc
Mar 16, 2022

PETHEMA-POMCIDEX Clinical Practice Guidelines for Treatment of

Completed
  • Relapsed and Refractory Multiple Myeloma
    • Barcelona, Spain
    • +26 more
    Feb 4, 2021

    Relapsed and Refractory Multiple Myeloma Trial in Worldwide (LGH447, BYL719)

    Completed
    • Relapsed and Refractory Multiple Myeloma
    • Houston, Texas
    • +7 more
    Dec 16, 2020

    Relapsed and Refractory Multiple Myeloma Trial in United States (Ixazomib)

    Completed
    Has Results
    • Relapsed and Refractory Multiple Myeloma
    • Tampa, Florida
    • +4 more
    Jun 19, 2019

    Multiple Myeloma, Relapsed and Refractory Multiple Myeloma, Genetic Condition Trial (Ixazomib/Pomalidomide/Dexamethasone)

    Not yet recruiting
    • Multiple Myeloma
    • +2 more
    • (no location specified)
    Sep 22, 2018

    Relapsed and Refractory Multiple Myeloma Trial in Shenzhen (BCMA CAR-T Cells)

    Unknown status
    • Relapsed and Refractory Multiple Myeloma
    • BCMA CAR-T Cells
    • Shenzhen, Guangdong, China
      Pregene Shenzhen Biotechnology Co., Ltd.
    Sep 6, 2018

    Relapsed and Refractory Multiple Myeloma Trial (Anti-BCMA CAR T cells)

    Unknown status
    • Relapsed and Refractory Multiple Myeloma
    • Anti-BCMA CAR T cells
    • (no location specified)
    Jun 14, 2018

    Relapsed and Refractory Multiple Myeloma Trial in Melbourne (CYT997)

    Terminated
    • Relapsed and Refractory Multiple Myeloma
    • Melbourne, Victoria, Australia
      The Alfred Hospital
    Jun 4, 2018

    Lymphoid Hematological Malignancies, Relapsed and Refractory Multiple Myeloma Trial in Canada, United States (CB-5083,

    Terminated
    • Lymphoid Hematological Malignancies
    • Relapsed and Refractory Multiple Myeloma
    • Duarte, California
    • +7 more
    Feb 23, 2018